These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21143454)

  • 1. Relationships between N-terminal pro B-type natriuretic peptide and incident disability and mortality in older community-dwelling adults: the Tsurugaya study.
    Hozawa A; Sugawara Y; Tomata Y; Kakizaki M; Ohmori-Matsuda K; Nakaya N; Kuriyama S; Fukao A; Tsuji I
    J Am Geriatr Soc; 2010 Dec; 58(12):2439-41. PubMed ID: 21143454
    [No Abstract]   [Full Text] [Related]  

  • 2. N-terminal-pro-B-type natriuretic peptide: universal marker of cardiovascular risk?
    Richards AM; Frampton CM
    Circulation; 2005 Jul; 112(1):9-11. PubMed ID: 15998694
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between serum adiponectin levels and disability-free survival among community-dwelling elderly individuals: The Tsurugaya Project.
    Hozawa A; Sugawara Y; Tomata Y; Kakizaki M; Tsuboya T; Ohmori-Matsuda K; Nakaya N; Kuriyama S; Fukao A; Tsuji I
    J Gerontol A Biol Sci Med Sci; 2012 May; 67(5):530-6. PubMed ID: 22016360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R; Allison MA; Criqui MH
    J Am Coll Cardiol; 2007 Jun; 49(22):2172-81. PubMed ID: 17543637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders.
    Godkar D; Bachu K; Dave B; Niranjan S; Khanna A
    Am J Ther; 2008; 15(2):150-6. PubMed ID: 18356635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker sensitivity and specificity require pre-test probability of disease diagnosis to be collated: additional points on the interpretation of pro-B-type natriuretic peptide triage of dyspnea in the Copenhagen Heart Study.
    MacFadyen RJ; Chuen MJ
    J Am Coll Cardiol; 2008 Apr; 51(13):1322-3; author reply 1323. PubMed ID: 18371568
    [No Abstract]   [Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
    N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke.
    Jensen JK; Atar D; Kristensen SR; Mickley H; Januzzi JL
    Am J Cardiol; 2009 Jul; 104(2):287-91. PubMed ID: 19576362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambui Cohort Study of Aging.
    Lima-Costa MF; Cesar CC; Peixoto SV; Ribeiro AL
    Am J Epidemiol; 2010 Jul; 172(2):190-6. PubMed ID: 20581155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natriuretic peptides as cardiac markers in clinical practice].
    Veien KT; Jensen JK; Hildebrandt P; Gøtze JP; Nielsen OW; Køber L
    Ugeskr Laeger; 2010 Jul; 172(30):2111-6. PubMed ID: 20654278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenarians.
    Vaes B; de Ruijter W; Degryse J; Westendorp RG; Gussekloo J
    J Am Geriatr Soc; 2009 May; 57(5):823-9. PubMed ID: 19470010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.
    Kurl S; Ala-Kopsala M; Ruskoaho H; Mäkikallio T; Nyyssönen K; Vuolteenaho O; Sivenius J; Salonen JT; Laukkanen JA
    Heart; 2009 Jul; 95(13):1067-71. PubMed ID: 19321489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.